Search Results - "Ilett, E."

Refine Results
  1. 1
  2. 2
  3. 3

    Lymphokine‐activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites by Jennings, V.A., Ilett, E.J., Scott, K.J., West, E.J., Vile, R., Pandha, H., Harrington, K., Young, A., Hall, G.D., Coffey, M., Selby, P., Errington‐Mais, F., Melcher, A.A.

    Published in International journal of cancer (01-03-2014)
    “…Reovirus is an oncolytic virus (OV), which acts by both direct tumor cell killing and priming of antitumor immunity. A major obstacle for effective oncolytic…”
    Get full text
    Journal Article
  4. 4

    Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy by Ilett, E, Kottke, T, Thompson, J, Rajani, K, Zaidi, S, Evgin, L, Coffey, M, Ralph, C, Diaz, R, Pandha, H, Harrington, K, Selby, P, Bram, R, Melcher, A, Vile, R

    Published in Gene therapy (01-01-2017)
    “…The anti-tumour effects associated with oncolytic virus therapy are mediated significantly through immune-mediated mechanisms, which depend both on the type of…”
    Get full text
    Journal Article
  5. 5

    Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity by Ilett, E J, Prestwich, R J, Kottke, T, Errington, F, Thompson, J M, Harrington, K J, Pandha, H S, Coffey, M, Selby, P J, Vile, R G, Melcher, A A

    Published in Gene therapy (01-05-2009)
    “…Reovirus is a naturally occurring oncolytic virus currently in early clinical trials. However, the rapid induction of neutralizing antibodies represents a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia by Parrish, C, Scott, G B, Migneco, G, Scott, K J, Steele, L P, Ilett, E, West, E J, Hall, K, Selby, P J, Buchanan, D, Varghese, A, Cragg, M S, Coffey, M, Hillmen, P, Melcher, A A, Errington-Mais, F

    Published in Leukemia (01-09-2015)
    “…The naturally occurring oncolytic virus (OV), reovirus, replicates in cancer cells causing direct cytotoxicity, and can activate innate and adaptive immune…”
    Get full text
    Journal Article
  8. 8

    Cell migration in paediatric glioma; characterisation and potential therapeutic targeting by Cockle, J V, Picton, S, Levesley, J, Ilett, E, Carcaboso, A M, Short, S, Steel, L P, Melcher, A, Lawler, S E, Brüning-Richardson, A

    Published in British journal of cancer (17-02-2015)
    “…Background: Paediatric high grade glioma (pHGG) and diffuse intrinsic pontine glioma (DIPG) are highly aggressive brain tumours. Their invasive phenotype…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The evolving role of dendritic cells in cancer therapy by Ilett, E J, Prestwich, R J D, Melcher, A A

    Published in Expert opinion on biological therapy (01-03-2010)
    “…Dendritic cells (DC) are a clear choice for use in cancer immunotherapy, and much research has focused on generating DC for clinical use. Although DC therapy…”
    Get more information
    Journal Article
  11. 11

    The Immune System — is it Relevant to Cancer Development, Progression and Treatment? by Prestwich, R.J, Errington, F, Hatfield, P, Merrick, A.E, Ilett, E.J, Selby, P.J, Melcher, A.A

    “…Abstract The ability of the immune system to effectively respond to human tumours is a matter of long-term controversy. There is an increasing body of recent…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients by Ilett, Emma E., Jørgensen, Mette, Noguera-Julian, Marc, Nørgaard, Jens Christian, Daugaard, Gedske, Helleberg, Marie, Paredes, Roger, Murray, Daniel D., Lundgren, Jens, MacPherson, Cameron, Reekie, Joanne, Sengeløv, Henrik

    Published in Blood advances (24-11-2020)
    “…Acute graft-versus-host disease (aGVHD) is a leading cause of transplantation-related mortality after allogeneic hematopoietic stem cell transplantation…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Thaumasite investigations to M4 overbridges by Collard-Jenkins, S.J., Ilett, E., Pearson-Kirk, D.

    Published in Cement & concrete composites (01-12-2003)
    “…In March 1998, thaumasite sulfate attack (TSA) was discovered affecting several buried raking supports of the Golden Valley Interchange at Junction 11 of the…”
    Get full text
    Journal Article
  17. 17

    HIGH GRADE GLIOMAS AND DIPG by Classen, C. F., William, D., Linnebacher, M., Farhod, A., Kedr, W., Elsabe, B., Fadel, S., Van Gool, S., De Vleeschouwer, S., Koks, C., Garg, A., Ehrhardt, M., Riva, M., Agostinis, P., Graf, N., Yao, T.-W., Yoshida, Y., Zhang, J., Ozawa, T., James, D., Nicolaides, T., Kebudi, R., Cakir, F. B., Gorgun, O., Agaoglu, F. Y., Darendeliler, E., Al-Kofide, A., Al-Shail, E., Khafaga, Y., Al-Hindi, H., Dababo, M., Haq, A. U., Anas, M., Barria, M. G., Siddiqui, K., Hassounah, M., Ayas, M., van Zanten, S. V., Jansen, M., van Vuurden, D., Huisman, M., Vugts, D., Hoekstra, O., van Dongen, G., Kaspers, G., Cockle, J., Ilett, E., Scott, K., Bruning-Richardson, A., Picton, S., Short, S., Melcher, A., Benesch, M., Warmuth-Metz, M., von Bueren, A. O., Hoffmann, M., Pietsch, T., Kortmann, R.-D., Eyrich, M., Rutkowski, S., Fruhwald, M. C., Faber, J., Kramm, C., Porkholm, M., Valanne, L., Lonnqvist, T., Holm, S., Lannering, B., Riikonen, P., Wojcik, D., Sehested, A., Clausen, N., Harila-Saari, A., Schomerus, E., Thorarinsdottir, H. K., Lahteenmaki, P., Arola, M., Thomassen, H., Saarinen-Pihkala, U. M., Kivivuori, S.-M., Buczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Morrison, A., Bouffet, E., Bartels, U., Becher, O., Hawkins, C., Gould, T. W. A., Rahman, C. V., Smith, S. J., Barrett, D. A., Shakesheff, K. M., Grundy, R. G., Rahman, R., Barua, N., Cronin, D., Gill, S., Lowisl, S.

    Published in Neuro-oncology (Charlottesville, Va.) (01-06-2014)
    Get full text
    Journal Article
  18. 18
  19. 19

    A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria by Batty, K T, Le, A T, Ilett, K F, Nguyen, P T, Powell, S M, Nguyen, C H, Truong, X M, Vuong, V C, Huynh, V T, Tran, Q B, Nguyen, V M, Davis, T M

    “…To investigate the pharmacokinetic and pharmacodynamic properties of artesunate (ARTS) and its active metabolite dihydroartemisinin (DHA) in Plasmodium vivax…”
    Get more information
    Journal Article
  20. 20

    2569. The Gut Microbiome and Acute Graft vs. Host Disease Risk in Hematopoietic Stem Cell Transplantation Recipients by Ilett, Emma E, Reekie, Joanne, Jørgensen, Mette, Murray, Daniel D, Noguera, Marc, Paredes, Roger, Nørgaard, Jens C, Daugaard, Gedske, Helleberg, Marie, Lundgren, Jens, MacPherson, Cameron, Sengeløv, Henrik

    Published in Open forum infectious diseases (23-10-2019)
    “…Abstract Background 16S rRNA gene-based studies report that allogeneic hematopoietic stem cell transplant (aHSCT) recipients with low bacterial diversity and…”
    Get full text
    Journal Article